SpringWorks Therapeutics, Inc.

NASDAQ:SWTX

34.71 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -53.53-39.919-87.385-94.322-79.437-77.925-73.42-74.178-72.388-69.05-61.801-56.072-41.041-47.01-29.78711.272-21.659-19.893-15.294-16.217-16.833-13.847-11.409-6.219-5.004-3.295-3.295
Depreciation & Amortization 0.8780.8440.7290.5380.4940.3820.2530.2550.2120.190.1080.1460.1190.1150.110.110.0950.0740.070.0650.0630.0430.0210.0080.0030.0030.003
Deferred Income Tax 0001.8351.0240.901000000.3010.2670.1590.2610000-4.9470000000
Stock Based Compensation 25.96326.24530.46225.06723.09822.97423.39518.92418.51818.42917.09411.88210.7128.7957.0553.0423.0432.5991.350.950.7880.6480.7230.2260.2340.3050.305
Change In Working Capital 55.34-31.179-24.1613.73.9215.406-13.61-0.16732.28210.686-4.698-2.8212.7714.1681-0.5533.6470.876-2.624-0.9742.3680.0653.4882.49-1.960.310.31
Accounts Receivables -8.4680-9.599-5.9300000000000000000000000
Change In Inventory -2.1080-2.113-3.10300000000000000000000000
Change In Accounts Payables 1.580.745-0.3852.0652.574-4.082-0.7533.0062.3950.537-1.770.926-1.4061.6750.8790.2860.155-0.708-1.0370.4970.0131.2620.1080.535-0.91500
Other Working Capital 64.336-31.924-12.06410.6681.3479.4880.753-3.17329.88710.149-2.928-3.7474.1772.4930.121-0.8393.4921.584-1.587-1.4712.355-1.1973.381.955-1.0450.310.31
Other Non Cash Items -54.032.21945.4420.4770.4390.4511.5640.9661.7720.6740.6090.2480.2430.2450.2571.1950.1740.1850.15.062.5011.210.1080.534-0.9160.4360.436
Operating Cash Flow -25.379-41.79-78.93-62.705-50.461-47.811-61.818-54.2-19.604-39.071-48.688-46.316-26.929-33.528-21.10415.066-14.7-16.159-16.398-16.063-11.113-13.091-7.177-3.495-6.727-2.242-2.242
Investing Activities:
Investments In Property Plant And Equipment 9.403-12.225-0.5772.302-3.622-3.088-2.977-1.756-3.528-2.525-2.387-1.504-0.335-0.132-0.045-0.054-0.167-0.261-0.16-0.04-0.084-0.285-0.261-0.2930.065-0.033-0.033
Acquisitions Net 8.2350-8.235-2.3023.6223.088-2.810.1960-4.201.5040.3350.1320.0450.054000-0.090000000
Purchases Of Investments -36.79-85.59-81.877-266.448-96.664-144.464-68.148-413.0970-44.711-23.242-86.56-77.966-54.524-86.373-250.727-127.396-64.567000000000
Sales Maturities Of Investments 75.5298.104103.917104.941134.885208.308172.52959.84389.7678.19352.053144.245114.08677.255.52800000000000
Other Investing Activites -27.720-8.2352.302-3.622-3.088101.581-10.19689.7629.28228.811-1.504-0.335-0.132-0.045-0.054-127.396-68.0670-0.090-3.500000
Investing Cash Flow 28.6480.28921.463-159.20534.59960.75698.604-355.0186.23226.75726.42456.18135.78522.544-30.918-222.781-127.563-68.328-0.16-0.13-0.084-3.785-0.261-0.2930.065-0.033-0.033
Financing Activities:
Debt Repayment 000000000000000000000000000
Common Stock Issued -10.23500299.30000.298340.443000.2440.4250.1290.359269.592000169.730000000
Common Stock Repurchased 7.416-0.919-6.497-0.253-0.264-0.352-1.9311.341-0.212-0.223-0.9060000000000000000
Dividends Paid 000000000000000000000000000
Other Financing Activities 1.2914.295.9450.0240.0220.010.0830.2980.3770.1351.1670.2440.4250.1290.3590.3810.4280.0780.0060.02169.7310163.957-0.048025.225.2
Financing Cash Flow 1.2913.371-0.552299.071-0.242-0.342-1.8480.298340.231-0.0880.2610.2440.4250.1290.359269.9730.4280.0780.0060.02169.7310163.957-0.024025.225.2
Other Information:
Effect Of Forex Changes On Cash 000-49.57439.20310.37100000000000000.540000000
Net Change In Cash 5.179-38.13-58.02277.161-16.10412.60334.938-408.912406.859-12.402-22.00310.1099.281-10.855-51.66362.258-141.835-84.409-16.552-15.633158.534-17.416156.519-3.812-6.66222.92622.926
Cash At End Of Period 85.07779.898118.031176.66699.505115.609103.00668.068476.9870.12182.523104.52694.41785.13695.991147.65485.396227.231311.64328.192343.825185.291202.70745.64849.4656.12222.926